Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Spectrum of KRAS variants in primary lung mucinous adenocarcinoma: implications for diagnosis, testing, and therapy.

Journal of the American Society of Cytopathology - 1 Jan 2026

Htoo Arkar, Malenie Renuka, Xing Juan

Abstract excerpt

INTRODUCTION: Primary lung mucinous adenocarcinoma (PLMAC) frequently harbors KRAS mutations; however, the distribution of KRAS variants in PLMAC remains under-characterized. This study aimed to investigate the KRAS mutational profile in PLMAC. MATERIALS AND METHODS: Cases of PLMAC (2018-2022) and primary lung nonmucinous adenocarcinomas (PLNMAC) (Oct-Dec 2022) were identified from pathology archives. Molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to DNA Mutational Analysis

Share to High-Throughput Nucleotide Sequencing

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 41644317
DOI: 10.1016/j.jasc.2026.01.002

Genes

KRAS

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Spectrum of KRAS variants in primary lung mucinous adenocarcinoma: implications for diagnosis, testing, and therapy.PMID 41644317Read ↗

The histopathological spectrum and molecular changes associated with KRAS G12C mutation in non-small cell lung carcinoma.Semantic proximity Read ↗

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer.Semantic proximity Read ↗

KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing.Semantic proximity Read ↗

Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.Semantic proximity Read ↗

Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patients.Semantic proximity Read ↗

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.Semantic proximity Read ↗

Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non-Squamous Non-Small Cell Lung Cancer (Non-SQ NSCLC) Patients in Queensland, Australia From 2014-2023.Semantic proximity Read ↗

Clinicopathological Characteristics and Prognostic Impact of KRAS Mutations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Distinct molecular subtypes of KRASG12C-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies.Semantic proximity Read ↗

[Gene mutation profiles and clinicopathological features of patients with non-small cell lung cancer harboring KRAS G12C mutation: a single-center retrospective study].Semantic proximity Read ↗

Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features.Semantic proximity Read ↗

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.